Cullinan Oncology Inc

NASDAQ:CGEM  
11.65
-0.30 (-2.51%)
4:01:34 PM EDT: $11.65 0.00 (0.00%)
Earnings Announcements

Cullinan Oncology Reports Q3 2022 Financial Results

Published: 11/14/2022 13:24 GMT
Cullinan Oncology Inc (CGEM) - Cullinan Oncology Provides Corporate Update and Reports Third Quarter 2022 Financial Results.
Cash and Investments $606.7 Million As of September 30.
Qtrly Loss per Share $0.54.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.67

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.78

More details on our Analysts Page.